Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section

NCT01571323 is registered in ClinicalTrials.gov with Qazvin University Of Medical Sciences as lead sponsor.

NCT NCT01571323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01571323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
Lead sponsor
Qazvin University Of Medical Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
February 29, 2012
Completion date
September 30, 2012
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post partum haemorrhage